Global Recombinant Proteins Market Research Report 2023(Status and Outlook)

Global Recombinant Proteins Market Research Report 2023(Status and Outlook)



Report Overview

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.

The Global Recombinant Proteins Market Size was estimated at USD 719.40 million in 2022 and is projected to reach USD 1240.94 million by 2029, exhibiting a CAGR of 8.10% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Recombinant Proteins market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant Proteins Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant Proteins market in any manner.

Global Recombinant Proteins Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abcam PLC

R&D Systems

Miltenyi Biotec

Thermo Fisher Scientific

Sigma Aldrich Company

GE Healthcare

Lonza

Merck KGaA

ProSpec Tany TechnoGene

Eurogentec (Kaneka Corporation)

PeproTech

BPS Bioscience

Reprocell

GenScript Biotech Corporation

Abnova Corporation

Market Segmentation (by Type)

Hormones

Growth Factors

Cytokines

Plasma Protein Factor

Recombinant Metabolic Enzymes

Immune Checkpoint Regulators

Others

Market Segmentation (by Application)

Residential

Commercial

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Recombinant Proteins Market

Overview of the regional outlook of the Recombinant Proteins Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Recombinant Proteins
1.2 Key Market Segments
1.2.1 Recombinant Proteins Segment by Type
1.2.2 Recombinant Proteins Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Recombinant Proteins Market Overview
2.1 Global Market Overview
2.1.1 Global Recombinant Proteins Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Recombinant Proteins Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Recombinant Proteins Market Competitive Landscape
3.1 Global Recombinant Proteins Sales by Manufacturers (2018-2023)
3.2 Global Recombinant Proteins Revenue Market Share by Manufacturers (2018-2023)
3.3 Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant Proteins Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Recombinant Proteins Sales Sites, Area Served, Product Type
3.6 Recombinant Proteins Market Competitive Situation and Trends
3.6.1 Recombinant Proteins Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant Proteins Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Recombinant Proteins Industry Chain Analysis
4.1 Recombinant Proteins Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Recombinant Proteins Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Recombinant Proteins Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Proteins Sales Market Share by Type (2018-2023)
6.3 Global Recombinant Proteins Market Size Market Share by Type (2018-2023)
6.4 Global Recombinant Proteins Price by Type (2018-2023)
7 Recombinant Proteins Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Proteins Market Sales by Application (2018-2023)
7.3 Global Recombinant Proteins Market Size (M USD) by Application (2018-2023)
7.4 Global Recombinant Proteins Sales Growth Rate by Application (2018-2023)
8 Recombinant Proteins Market Segmentation by Region
8.1 Global Recombinant Proteins Sales by Region
8.1.1 Global Recombinant Proteins Sales by Region
8.1.2 Global Recombinant Proteins Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant Proteins Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant Proteins Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant Proteins Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant Proteins Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant Proteins Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abcam PLC
9.1.1 Abcam PLC Recombinant Proteins Basic Information
9.1.2 Abcam PLC Recombinant Proteins Product Overview
9.1.3 Abcam PLC Recombinant Proteins Product Market Performance
9.1.4 Abcam PLC Business Overview
9.1.5 Abcam PLC Recombinant Proteins SWOT Analysis
9.1.6 Abcam PLC Recent Developments
9.2 Randamp;D Systems
9.2.1 Randamp;D Systems Recombinant Proteins Basic Information
9.2.2 Randamp;D Systems Recombinant Proteins Product Overview
9.2.3 Randamp;D Systems Recombinant Proteins Product Market Performance
9.2.4 Randamp;D Systems Business Overview
9.2.5 Randamp;D Systems Recombinant Proteins SWOT Analysis
9.2.6 Randamp;D Systems Recent Developments
9.3 Miltenyi Biotec
9.3.1 Miltenyi Biotec Recombinant Proteins Basic Information
9.3.2 Miltenyi Biotec Recombinant Proteins Product Overview
9.3.3 Miltenyi Biotec Recombinant Proteins Product Market Performance
9.3.4 Miltenyi Biotec Business Overview
9.3.5 Miltenyi Biotec Recombinant Proteins SWOT Analysis
9.3.6 Miltenyi Biotec Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Recombinant Proteins Basic Information
9.4.2 Thermo Fisher Scientific Recombinant Proteins Product Overview
9.4.3 Thermo Fisher Scientific Recombinant Proteins Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recombinant Proteins SWOT Analysis
9.4.6 Thermo Fisher Scientific Recent Developments
9.5 Sigma Aldrich Company
9.5.1 Sigma Aldrich Company Recombinant Proteins Basic Information
9.5.2 Sigma Aldrich Company Recombinant Proteins Product Overview
9.5.3 Sigma Aldrich Company Recombinant Proteins Product Market Performance
9.5.4 Sigma Aldrich Company Business Overview
9.5.5 Sigma Aldrich Company Recombinant Proteins SWOT Analysis
9.5.6 Sigma Aldrich Company Recent Developments
9.6 GE Healthcare
9.6.1 GE Healthcare Recombinant Proteins Basic Information
9.6.2 GE Healthcare Recombinant Proteins Product Overview
9.6.3 GE Healthcare Recombinant Proteins Product Market Performance
9.6.4 GE Healthcare Business Overview
9.6.5 GE Healthcare Recent Developments
9.7 Lonza
9.7.1 Lonza Recombinant Proteins Basic Information
9.7.2 Lonza Recombinant Proteins Product Overview
9.7.3 Lonza Recombinant Proteins Product Market Performance
9.7.4 Lonza Business Overview
9.7.5 Lonza Recent Developments
9.8 Merck KGaA
9.8.1 Merck KGaA Recombinant Proteins Basic Information
9.8.2 Merck KGaA Recombinant Proteins Product Overview
9.8.3 Merck KGaA Recombinant Proteins Product Market Performance
9.8.4 Merck KGaA Business Overview
9.8.5 Merck KGaA Recent Developments
9.9 ProSpec Tany TechnoGene
9.9.1 ProSpec Tany TechnoGene Recombinant Proteins Basic Information
9.9.2 ProSpec Tany TechnoGene Recombinant Proteins Product Overview
9.9.3 ProSpec Tany TechnoGene Recombinant Proteins Product Market Performance
9.9.4 ProSpec Tany TechnoGene Business Overview
9.9.5 ProSpec Tany TechnoGene Recent Developments
9.10 Eurogentec (Kaneka Corporation)
9.10.1 Eurogentec (Kaneka Corporation) Recombinant Proteins Basic Information
9.10.2 Eurogentec (Kaneka Corporation) Recombinant Proteins Product Overview
9.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Product Market Performance
9.10.4 Eurogentec (Kaneka Corporation) Business Overview
9.10.5 Eurogentec (Kaneka Corporation) Recent Developments
9.11 PeproTech
9.11.1 PeproTech Recombinant Proteins Basic Information
9.11.2 PeproTech Recombinant Proteins Product Overview
9.11.3 PeproTech Recombinant Proteins Product Market Performance
9.11.4 PeproTech Business Overview
9.11.5 PeproTech Recent Developments
9.12 BPS Bioscience
9.12.1 BPS Bioscience Recombinant Proteins Basic Information
9.12.2 BPS Bioscience Recombinant Proteins Product Overview
9.12.3 BPS Bioscience Recombinant Proteins Product Market Performance
9.12.4 BPS Bioscience Business Overview
9.12.5 BPS Bioscience Recent Developments
9.13 Reprocell
9.13.1 Reprocell Recombinant Proteins Basic Information
9.13.2 Reprocell Recombinant Proteins Product Overview
9.13.3 Reprocell Recombinant Proteins Product Market Performance
9.13.4 Reprocell Business Overview
9.13.5 Reprocell Recent Developments
9.14 GenScript Biotech Corporation
9.14.1 GenScript Biotech Corporation Recombinant Proteins Basic Information
9.14.2 GenScript Biotech Corporation Recombinant Proteins Product Overview
9.14.3 GenScript Biotech Corporation Recombinant Proteins Product Market Performance
9.14.4 GenScript Biotech Corporation Business Overview
9.14.5 GenScript Biotech Corporation Recent Developments
9.15 Abnova Corporation
9.15.1 Abnova Corporation Recombinant Proteins Basic Information
9.15.2 Abnova Corporation Recombinant Proteins Product Overview
9.15.3 Abnova Corporation Recombinant Proteins Product Market Performance
9.15.4 Abnova Corporation Business Overview
9.15.5 Abnova Corporation Recent Developments
10 Recombinant Proteins Market Forecast by Region
10.1 Global Recombinant Proteins Market Size Forecast
10.2 Global Recombinant Proteins Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant Proteins Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant Proteins Market Size Forecast by Region
10.2.4 South America Recombinant Proteins Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant Proteins by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Recombinant Proteins Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Recombinant Proteins by Type (2024-2029)
11.1.2 Global Recombinant Proteins Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Recombinant Proteins by Type (2024-2029)
11.2 Global Recombinant Proteins Market Forecast by Application (2024-2029)
11.2.1 Global Recombinant Proteins Sales (K Units) Forecast by Application
11.2.2 Global Recombinant Proteins Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings